Cronos Group (NASDAQ:CRON,TSX:CRON) announced today that it has entered into an agreement to acquire an 84,000 square foot GMP compliant fermentation and manufacturing facility in Winnipeg, Canada from Apotex Fermentation.

As quoted in the press release:


The state-of-the-art facility, which will operate as “Cronos Fermentation”, includes fully equipped laboratories covering microbiology, organic and analytical chemistry, quality control and method development as well as two large scale microbial fermentation production areas with combined production capacity of 102,000L, three downstream processing plants, and bulk product and packaging capabilities.

As previously announced, Cronos Group has entered into a partnership with Ginkgo Bioworks, Inc. (“Ginkgo”) to produce cultured cannabinoids. Research and development under this partnership is progressing, and as associated milestones are hit, this new facility is expected to provide Cronos Group with the ability to produce cultured cannabinoids at commercial scale with high-quality and high-purity.

“This acquisition will provide the fermentation and manufacturing capabilities we need to capitalize on the work underway with Ginkgo once the milestones under that partnership are achieved,” said Mike Gorenstein, CEO of Cronos Group. “Together with Ginkgo, we are bringing innovation and the power of biological manufacturing to the cannabis industry, aiming to allow for cannabinoid production at large scale and with greater efficiency than is currently possible with traditional cultivation and extraction. We continue to be very excited about the opportunities ahead.”

Click here to read the full press release.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Cannabis research firm New Frontier Data has released a new report in which it projects that the value of the total cannabis industry will reach US$51 billion by the year 2025.

Also this week, a few cannabis companies announced new international ventures. This side of the space is full of potential, but is relatively new compared to markets like the US and Canada.

Keep reading... Show less

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“the Company”) today announced that it has officially launched its new cold storage services for 3rd party manufacturers with the onboarding of its first client, Kase Manufacturing (‘Kase’).

Kase will rent portions of TransCanna‘s 4,400 square foot, state-of-the-art cold storage cannabis freezer for specialized storage of Kase’s fresh-frozen cannabis biomass. The sub-40 degree Fahrenheit cannabis freezer, roughly the size of a five bedroom house, is the largest of its kind in Northern California.

Keep reading... Show less

Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder” or the “Company”), an established Canadian cannabis and vape retailer, is pleased to announce that further to its press release dated August 26, 2021, all of its issued and outstanding common shares (the “Common Shares”) will begin trading on a post-consolidation basis on September 17, 2021 at the commencement of trading on the TSX Venture Exchange (“TSXV”).

On August 26, 2021, the Company announced that the Common Shares would be consolidated on the basis of one (1) post-consolidation Common Share for each five (5) pre-consolidation Common Shares (the “Share Consolidation“).

Keep reading... Show less

 TerrAscend Corp. (“TerrAscend” or the “Company”) (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced that it has received pre-qualification approval for cultivation, processing and retail licenses from the state of Michigan’s Marijuana Regulatory Agency pursuant to the Medical Marihuana Facilities Licensing Act. The pre-qualification approval represents TerrAscend’s successful completion of the most comprehensive portion of the State’s licensing and regulatory approval process. The pre-qualification approval is a key closing condition for TerrAscend’s previously announced acquisition of Gage Growth Corp.(“Gage”) (the “Transaction”). The Transaction will close as soon as possible after receipt of the applicable shareholder, court and other regulatory approvals and satisfaction or waiver of all other conditions in the definitive arrangement agreement (the “Arrangement Agreement”).

Keep reading... Show less

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness Company offering premium probiotic supplements and products containing CBD, is pleased to announce it has increased the size of its previously announced non-brokered private placement from USD $2,000,000 to over USD $2,500,000 (the “Private Placement”). This increase is designed to accommodate additional demand that the Company has received in the financing.

Keep reading... Show less